You are here

  • Home
  • Archive
  • Volume 77, Issue 5
  • Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study

Article Text

Article menu
Download PDFPDF
Letter
Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study

https://doi.org/10.1136/annrheumdis-2017-211322

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors All authors made substantial intellectual contributions to conception of the work, the interpretation of data and approval of the final manuscript. T-YH and Y-MC conceived of the study, generated the original hypothesis, designed the study, and drafted and revised the manuscript. W-NH, Y-DW, C-TL and Y-HC acquired clinical data and analysed data. D-YC conceived of the study, analysed data and revised the manuscript.

    • Funding This study was supported by a grant from Taichung Veterans General Hospital, Taiwan (TCVGH-1057309C).

    • Competing interests None declared.

    • Patient consent Obtained.

    • Ethics approval Institution Review Board of Taichung Veterans General Hospital.

    • Provenance and peer review Not commissioned; externally peer reviewed.